:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Mario Pagliaro, Giovanna Li Petri, Giuseppe Angellotti, Rosaria Ciriminna
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	ChemMedChem
Accesso online:	https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70332
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Investigating the Ligand‐Binding Properties of N‐arylbenzimidazoles as Novel Elastase Inhibitors
di: Giovanna Pitasi, et al.
Pubblicazione: (2025)

New Conjugates of Hyaluronic Acid with γ‐Cyclodextrin as Sorafenib Carrier in Cancer Cells
di: Noemi Bognanni, et al.
Pubblicazione: (2024)

Inhibition of polymorphic MexXY‐OprM efflux system in Pseudomonas aeruginosa clinical isolates by Berberine derivatives
di: Giorgia Giorgini, et al.
Pubblicazione: (2024)

Addressing Data Point Homogeneity and Annotation Challenges to Enhance Data‐Driven Approaches: The S. aureus NorA Efflux Pump Case Study
di: Andrea Astolfi, et al.
Pubblicazione: (2025)

Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase
di: Alessandra Feoli, et al.
Pubblicazione: (2026)

Silicon Phthalocyanines Functionalized with Axial Substituents Targeting PSMA: Synthesis and Preliminary Assessment of Their Potential for PhotoDynamic Therapy of Prostate Cancer
di: Martina Capozza, et al.
Pubblicazione: (2024)

Optimization of 4‐Amino‐2‐Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure–Activity and Structure–Metabolism Relationships
di: Lisa Giannessi, et al.
Pubblicazione: (2025)

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
di: Ilaria Cursaro, et al.
Pubblicazione: (2024)

Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer‐Related Pathways
di: Dafne Ruggiero, et al.
Pubblicazione: (2025)

Structural Analysis of the Macrocyclic Inhibitor BI‐4020 Binding to EGFR Kinase
di: Tyler S. Beyett, et al.
Pubblicazione: (2024)

3′‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure–Activity Relationship Analysis, and Structural Characterization of Protein Complex
di: Michal Kráľ, et al.
Pubblicazione: (2025)

3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex
di: Michal Kráľ, et al.
Pubblicazione: (2024)

Benzofurans as Acetylcholinesterase Inhibitors for Treating Alzheimer's Disease: Synthesis, in vitro Testing, and in silico Analysis
di: Arturo Coaviche‐Yoval, et al.
Pubblicazione: (2024)

4‐(5‐Chloro‐3‐(3,4,5‐trimethoxybenzoyl)‐1 H ‐indol‐1‐yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β‐Catenin Signaling Pathway, and P‐Glycoprotein
di: Michela Puxeddu, et al.
Pubblicazione: (2026)

Front Cover: 3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex (ChemMedChem 3/2025)
di: Michal Kráľ, et al.
Pubblicazione: (2025)

Significant Tumor Inhibition of Trimethyl‐152‐[L‐aspartyl]pheophorbide a in Tumor Photodynamic Therapy≠
di: Anita Benić, et al.
Pubblicazione: (2025)

Quantum Osteoimmunology: A Paradigm Shift in Understanding and Influencing Bone–Immune Crosstalk
di: Rachel Wei Li, et al.
Pubblicazione: (2025)

Novel 4,5‐Dihydrothiazole‐Phenylpiperazine Derivatives: Synthesis, Docking Studies and Pharmacological Evaluation as Serotonergic Agents
di: Giorgia Andreozzi, et al.
Pubblicazione: (2025)

Front Cover: Novel 4,5‐Dihydrothiazole‐Phenylpiperazine Derivatives: Synthesis, Docking Studies and Pharmacological Evaluation as Serotonergic Agents (ChemMedChem 15/2025)
di: Giorgia Andreozzi, et al.
Pubblicazione: (2025)

Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor
di: Mario Saletti, et al.
Pubblicazione: (2025)

Cyclic Peptides Radiopharmaceuticals: A Concise Review of Ligand Identification, Radiolabeling, and Clinical Progress
di: Xiushuang Yuan, et al.
Pubblicazione: (2026)

Discovery of New CDDO‐Imidazole Derivatives as Potential Antitumor Agents
di: Yanqing Li, et al.
Pubblicazione: (2026)

Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis
di: Igor Resendes Barbosa, et al.
Pubblicazione: (2025)

Design, Synthesis, Antimicrobial, and Antimalarial Evaluation of Quinoline Hydrazone Derivatives: Insight through Density Functional Theory Analysis, Molecular Docking, and Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictions
di: Sangeeta Verma, et al.
Pubblicazione: (2025)

Developing Dynamic Structure‐Based Pharmacophore and ML‐Trained QSAR Models for the Discovery of Novel Resistance‐Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis
di: Ehsan Sayyah, et al.
Pubblicazione: (2024)

Design, Synthesis and Preliminary Bioactivity Evaluation of N‐Acetylcysteine Derivatives as Antioxidative and Anti‐Inflammatory Agents
di: Genjv Li, et al.
Pubblicazione: (2024)

Insights into the Overcoming EGFRDel19/T790M/C797S Mutation: A Perspective on the 2‐Aryl‐4‐aminothienopyrimidine Backbone
di: Xuan Zhang, et al.
Pubblicazione: (2024)

Ac34deoGlcNAz: A Selective Probe for Identifying O‐GlcNAc‐Modified Proteins in Prostate Cancer
di: Guoliang Xu, et al.
Pubblicazione: (2024)

A Novel Synthetic Route for Lysine‐Specific Demethylase 1‐Targeting Compounds: CC‐90011 and MS9117
di: Jingying Wang, et al.
Pubblicazione: (2026)

Front Cover: Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis (ChemMedChem 9/2025)
di: Igor Resendes Barbosa, et al.
Pubblicazione: (2025)

Screening Methods for Cervical Cancer
di: Jingyan Li, et al.
Pubblicazione: (2024)

Nano‐Engineering Strategies for Tumor‐Specific Therapy
di: Zijin Li, et al.
Pubblicazione: (2024)

Front Cover: Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors (ChemMedChem 21/2025)
di: Yaojia Li, et al.
Pubblicazione: (2025)

Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors
di: Yaojia Li, et al.
Pubblicazione: (2025)

Synthesis of trans‐Fused 3,6‐Anhydro Hexofuranose Frameworks via Catalytic Hydrogenolysis Triggered Debenzylative Intramolecular Acetalation
di: Yu Li, et al.
Pubblicazione: (2025)

Natural Staurosporine Derivatives with Fluorescence for Cancer Theranostics
di: Kualiang Li, et al.
Pubblicazione: (2025)

Novel Folate–Phenylfuran P‐gp Inhibitor Conjugates for Overcoming Multidrug Resistance in MCF‐7/ADR Cell
di: Qin Wang, et al.
Pubblicazione: (2025)

Novel Vancomycin‐β‐Lactam Hybrids: Structure–Activity Relationships and Therapeutic Potential Against VISA and VRE
di: Taopeng Chang, et al.
Pubblicazione: (2026)

Pillar[n]arene‐Based Supramolecular Nanodrug Delivery Systems for Cancer Therapy
di: Shubin Wei, et al.
Pubblicazione: (2025)

The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
di: Qiuying Nie, et al.
Pubblicazione: (2024)